Crinetics Pharmaceuticals, Inc.
CRNX
$35.71
-$0.34-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.03B | 1.09B | 1.20B | 1.27B | 1.35B |
| Total Receivables | 592.00K | -- | -- | 7.31M | -- |
| Inventory | 2.02M | -- | -- | -- | -- |
| Prepaid Expenses | 17.84M | 28.48M | 20.40M | 5.25M | 20.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 500.00K | 500.00K | 4.37M | 500.00K |
| Total Current Assets | 1.05B | 1.12B | 1.22B | 1.29B | 1.38B |
|
|
|||||
| Total Current Assets | 1.05B | 1.12B | 1.22B | 1.29B | 1.38B |
| Net Property, Plant & Equipment | 54.79M | 55.52M | 56.57M | 55.32M | 55.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.13M | 19.23M | 15.74M | 12.95M | 3.63M |
| Total Assets | 1.13B | 1.20B | 1.29B | 1.36B | 1.43B |
|
|
|||||
| Total Accounts Payable | 22.61M | 6.11M | 11.33M | 9.84M | 5.85M |
| Total Accrued Expenses | 54.74M | 59.96M | 48.56M | 38.38M | 44.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.49M | 6.44M | 6.61M | 6.88M | 7.15M |
| Total Finance Division Other Current Liabilities | 1.24M | 1.64M | 1.90M | 2.21M | 2.18M |
| Total Other Current Liabilities | 1.24M | 1.64M | 1.90M | 2.21M | 2.18M |
| Total Current Liabilities | 85.07M | 74.16M | 68.40M | 57.31M | 59.68M |
|
|
|||||
| Total Current Liabilities | 85.07M | 74.16M | 68.40M | 57.31M | 59.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.05M | 42.70M | 43.33M | 43.94M | 44.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.05M | 7.00M | 6.33M | 6.08M | 5.53M |
| Total Liabilities | 134.17M | 123.86M | 118.05M | 107.33M | 109.79M |
|
|
|||||
| Common Stock & APIC | 2.41B | 2.36B | 2.33B | 2.30B | 2.28B |
| Retained Earnings | -1.42B | -1.29B | -1.16B | -1.05B | -952.11M |
| Treasury Stock & Other | 1.75M | 2.08M | 1.51M | 2.00M | 963.00K |
| Total Common Equity | 992.08M | 1.07B | 1.17B | 1.25B | 1.32B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 992.08M | 1.07B | 1.17B | 1.25B | 1.32B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 992.08M | 1.07B | 1.17B | 1.25B | 1.32B |
|
|
|||||